NCT01276431已完成4 期
Norspan Efficacy and Safety Among Elderly Subjects
适应症
干预措施
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 102
- 试验地点
- 2
- 主要终点
- Box Scale-11 (BS-11) pain scores (pain on average during the last seven days, mean change from Baseline to Completion (fulfilled all visits in the study).
研究概览
简要总结
An open label, multi-centre, prospective age-group-controlled study to evaluate efficacy and safety of buprenorphine transdermal patches in subjects with chronic, moderate to severe osteoarthritis pain of the hip and/or knee.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 50 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Buprenorphine transdermal patch
Other
For two age groups: 50-60 years and >= 75 years of age
干预措施: Buprenorphine transdermal patch (Drug)
结局指标
主要结局
Box Scale-11 (BS-11) pain scores (pain on average during the last seven days, mean change from Baseline to Completion (fulfilled all visits in the study).
次要结局
- Western Ontario & McMaster Universities OA Index
- European QOL Health Questionnaire
- Sleep disturbance & quality of sleep questions
- Patients global assessment of pain relief
- Investigators global assessment of pain relief
- Incidence of rescue medication
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of AgeAlzheimer's DiseaseNCT02576639Novartis Pharmaceuticals124
已完成
不适用
Safety and Efficacy of Long-term Somatropin Treatment in AdultsGrowth Hormone DisorderAdult Growth Hormone DeficiencyNCT01543880Novo Nordisk A/S752
已完成
不适用
Rejuvant™ Safety and Biomarker StudyAging WellNCT04821401Ponce De Leon Health100
撤回
4 期
Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 WeeksHypogonadismNCT00710827Bayer
招募中
2 期
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential ThrombocythemiaEssential ThrombocytopeniaNCT05395507Institute of Hematology & Blood Diseases Hospital, China194
